Healthcare Costs of Long-Acting Insulin Analogs vs NPH Insulin in Type 2 Diabetes Patients Using a Basal Regimen in Denmark

被引：0

|

作者：

Gundgaard, Jens

Aagren, Mark

Thomsen, Trine L.

机构：

来源：

DIABETES | 2009年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A316 / A317

页数：2

相关论文

共 50 条

[31] Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes
C. Schmid
P. Krayenbühl
P. Wiesli
Diabetologia, 2009, 52 : 2668 - 2669
[32] Insulin therapy in type 2 diabetes:: role of the long-acting insulin glargine analogue
Yki-Järvinen, H
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (06) : 410 - 416
[33] Comparing efficiency of insulin glargine vs. NPH insulin in patients with type 2 diabetes
Kodela, B.
Petrovic, J.
Velickovic-Radovanovic, R.
Lilic, R.
Radenkovic, S.
Dedovic, I
VALUE IN HEALTH, 2007, 10 (06) : A254 - A254
[34] Restoration of Postprandial Insulin Secretion with Long-Acting Basal Insulin. Replacement in Korean Type 2 Diabetes Patients on Sulfonylurea Based Treatment
Cho, Jae Hyoung
Shin, Jeong Ah
Kim, Min Hee
Kim, Ji Won
Ham, Dong Sik
Sun, Cheng Lin
Park, Shin Ae
Lee, Seung Hwan
Kwon, Hyuk Sang
Ahn, Yu Bae
Yoon, Kun Ho
DIABETES, 2009, 58 : A535 - A535
[35] Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes A systematic review and meta-analysis
Szypowska, Agnieszka
Golicki, Dominik
Groele, Lidia
Pankowska, Ewa
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (7-8): : 237 - 246
[36] Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes
Edith M. Heintjes
Trine L. Thomsen
Fernie J. A. Penning-van Beest
Torsten E. Christensen
Ron M. C. Herings
Advances in Therapy, 2010, 27 : 211 - 222
[37] Glycemic Control and Long-Acting Insulin Analog Utilization in Patients with Type 2 Diabetes
Heintjes, Edith M.
Thomsen, Trine L.
Penning-van Beest, Fernie J. A.
Christensen, Torsten E.
Herings, Ron M. C.
ADVANCES IN THERAPY, 2010, 27 (04) : 211 - 222
[38] Effect of Dulaglutide and Long-Acting Insulin Combination Therapy in Patients with Type 2 Diabetes
Ito, Kohei
Kondo, Yoshinobu
Satoh, Shinobu
Terauchi, Yasuo
DIABETES, 2018, 67
[39] Assessment of treatment satisfaction in long-acting insulin analogues: Evidence from a basal-bolus regimen treating type 1 diabetic patients with insulin detemir vs. insulin glargine
Brod, Meryl
Lammert, Morten
DIABETES, 2006, 55 : A558 - A558
[40] Type 2 diabetes: Which long-acting insulin should be preferred?
Nauck, Michael
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (34-35) : 1678 - 1678

← 1 2 3 4 5 →